These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17760943)

  • 1. Photosensitisation induced by clofazimine in a cat.
    Bennett Sl
    Aust Vet J; 2007 Sep; 85(9):375-80. PubMed ID: 17760943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of localized Mycobacterium avium complex infection with clofazimine and doxycycline in a cat.
    Kaufman AC; Greene CE; Rakich PM; Weigner DD
    J Am Vet Med Assoc; 1995 Aug; 207(4):457-9. PubMed ID: 7591945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Small intestine transit anomalies in a patient with chronic abdominal pain and treated for Hansen's disease].
    Davy C; Riveau E; Bousquet JC; Curet P; Vayre P; Cortez A; Grellet J
    J Radiol; 1986 Mar; 67(3):213-8. PubMed ID: 3528476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofazimine: new products. Major antileprous drug.
    Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileprosy drugs, pregnancy and fetal outcome.
    Bhargava P; Kuldeep CM; Mathur NK
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):457-8. PubMed ID: 9030117
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.
    Mathew BS; Pulimood AB; Prasanna CG; Ramakrishna BS; Chandy SJ
    Trop Gastroenterol; 2006; 27(2):87-8. PubMed ID: 17089619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of clofazimine in dermatology.
    Gurfinkel P; Pina JC; Ramos-e-Silva M
    J Drugs Dermatol; 2009 Sep; 8(9):846-51. PubMed ID: 19746677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual cause of small-intestine mucosal pigmentation.
    Raftopoulos SC; Fermoyle S
    Gastrointest Endosc; 2011 Jun; 73(6):1285-6. PubMed ID: 21354567
    [No Abstract]   [Full Text] [Related]  

  • 10. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM; Reis AC; De Rezende TM; Borges AS; Ferreira MS; Nishioka SA
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract]   [Full Text] [Related]  

  • 11. Adverse effects from multi-drug therapy in leprosy: a Brazilian study.
    Deps PD; Nasser S; Guerra P; Simon M; Birshner Rde C; Rodrigues LC
    Lepr Rev; 2007 Sep; 78(3):216-22. PubMed ID: 18035772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.
    Pais AV; Pereira S; Garg I; Stephen J; Antony M; Inchara YK
    Lepr Rev; 2004 Jun; 75(2):171-6. PubMed ID: 15282969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofazimine-induced enteropathy in a patient of leprosy.
    Singh H; Azad K; Kaur K
    Indian J Pharmacol; 2013; 45(2):197-8. PubMed ID: 23716903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in paucibacillary leprosy.
    Gupta M
    Indian J Lepr; 2000; 72(2):247. PubMed ID: 11008665
    [No Abstract]   [Full Text] [Related]  

  • 15. Clofazimine should be used in all cases of leprosy, says Indian research council.
    Bhaumik S
    BMJ; 2013 Mar; 346():f1963. PubMed ID: 23533127
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of Hansen's disease.
    Alto WA
    Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety of clofazimine and pentoxifylline in type 2 lepra reaction: a double-blind, randomized, controlled study.
    Roy K; Sil A; Das NK; Bandyopadhyay D
    Int J Dermatol; 2015 Nov; 54(11):1325-32. PubMed ID: 26094723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion of clofazimine in human milk in leprosy patients.
    Venkatesan K; Mathur A; Girdhar A; Girdhar BK
    Lepr Rev; 1997 Sep; 68(3):242-6. PubMed ID: 9364825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 20. Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine.
    Freerksen E; Seydel JK
    Arzneimittelforschung; 1992 Oct; 42(10):1243-5. PubMed ID: 1472145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.